Companies / Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc.

Nasdaq: STOKCIK 1623526BEDFORD, MA

Financials · FY2025

Revenue$184.42M
Net income$-6.88M
Total debt—
Cash$110.00M
Diluted EPS$-0.12
Shares outstanding64.5M

Ownership

64.5M shares outstanding · as of Jul 30, 2026
0.70%Insiders
Ownership
Insiders0.70%450,200
10%+ / strategic8.68%5,600,920
Institutions99.59%64,258,831
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Krainer Adrian R.Director
0.44%283,302
Kaye Edward M. MDDirector
0.17%110,874
Ticho BarryFormerCHIEF MEDICAL OFFICER
0.06%40,702
Tzianabos ArthurInterim Executive Chair · Director
0.05%31,339
Allan JonathanFormerGENERAL COUNSEL & CORP SEC
0.03%19,543
Hoitt JasonChief Patient Officer
0.02%10,276
Leggett ThomasChief Financial Officer
0.02%10,172
Levin Arthur aDirector
<0.01%4,237
Smith Ian FCEOChief Executive Officer · Director
——

Institutional holders 195

View all →
HolderValue% of shares
BlackRock, Inc.$192.31M9.11%
Fmr LLC$177.77M8.68%
RTW Investments, LP$176.06M8.60%
Lynx1 Capital Management LP$171.54M8.38%
Redmile Group, LLC$128.04M6.25%
Morgan Stanley$112.56M5.50%
Baker Bros. Advisors LP$108.64M5.17%
Toronto Dominion Bank$100.72M4.92%
Vanguard Group Inc$99.96M4.88%
State Street Corporation$93.33M4.42%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 10, 2026Krainer Adrian R.
Director
SellCommon Stock$1.32M-33K
-10.50%
283,302
0.44% of shares
medium
Mar 20, 2026Allan Jonathan
Executive
SellCommon Stock$292.4K-9K
-30.14%
20,144
0.03% of shares
medium
Mar 2, 2026Krainer Adrian R.
Director
SellCommon Stock$286.7K-7K
-2.23%
316,545
0.49% of shares
medium
Mar 18, 2026Ticho Barry
Executive
SellCommon Stock$190.8K-6K
-12.85%
41,384
0.06% of shares
medium
Mar 10, 2026Tzianabos Arthur
Executive
SellCommon Stock$174.2K-4K
-12.20%
31,339
0.05% of shares
medium
Mar 18, 2026Allan Jonathan
Executive
SellCommon Stock$132.1K-4K
-12.62%
29,242
0.05% of shares
medium
Mar 17, 2026Ticho Barry
Executive
SellCommon Stock$117.1K-4K
-6.67%
50,071
0.08% of shares
medium
Mar 17, 2026Ticho Barry
Executive
SellCommon Stock$86.3K-3K
-5.17%
47,484
0.07% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Baker Bros. Advisors LPPassive13G/A———
Fmr LLCPassive13G/A—5,600,920—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
STOK——86150R107—